Skip to content

The effect of walk training with blood flow restriction in patients undergoing maintenance hemodialysis

The effect of walk training with blood flow restriction in patients undergoing maintenance hemodialysis: a randomized control trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400080779
Enrollment
Unknown
Registered
2024-02-06
Start date
2024-02-08
Completion date
Unknown
Last updated
2024-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease

Interventions

walk training with blood flow restriction:walking training with blood flow restriction
walk training:walking training
Usual care:Usual care

Sponsors

Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. adults (age = 18 years), 2. MHD = three months, 3. hemodialysis three sessions per week, 4. ability to walking without assistive from other persons and equipment, 5. ability to understand exercise instruction, and 6. ability to read Chinese.

Exclusion criteria

Exclusion criteria: 1. exercise regularly (i.e., >150 minutes per week of aerobic exercise or structured resistance exercise > one session per week), 2. contraindications to exercise training (e.g., musculoskeletal factors and neurological conditions), 3. higher risk of hemodynamic when conduct exercise: SBP = 180 mmHg or DBP = 105 mmHg before dialysis, rest heart rate = 120 beats per minute, gains above 4 kg of weight since last dialysis/exercise session, symptomatic heart failure, severe arrhythmia, etc., 4. high risk of BFR implementation: coagulation or presence of signs of thrombophlebitis, diagnosis of peripheral vascular disease or with symptoms suggestive of peripheral vascular disease, peripheral edema, skin damage of any low limb, etc., 5. had a single-pool Kt/V (spKt/V) value of < 1.2 [56]. 6. with lower limb deep vein catheterization or lower limb arteriovenous fistula.

Design outcomes

Primary

MeasureTime frame
6-minute walking test;

Secondary

MeasureTime frame
Handgrip strength (HGS);30-second sit-to-stand-to-sit test (STS30);Time up-and-go test (tug);Health-related quality of life;Anxiety;Depression;

Countries

China

Contacts

Public ContactHU Huagang, JIANG Xiaomei, XU Qinjuan

Soochow University; The Second Affiliated Hospital of Soochow University; The First Affiliated Hospital of Soochow University,

huhuagang@suda.edu.cn+86 139 1310 3099

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026